MMCAP Infuse RFP for Generic/Multisource Pharmaceuticals and Over the Counter Products, Reference #: 35260

Solicitation # 35260
Posted 1/17/25, 1:46 PM
No Updates
Due 3/5/25, 6:00 PM
State
Alaska
Source
View
Similar Opportunities
Not listed

The State of Alaska, on behalf of MMCAP Infuse, is releasing a Request for Proposals (RFP) for Generic/Multisource Pharmaceuticals and Over the Counter Products, with reference number 35260. MMCAP Infuse is a national cooperative group purchasing organization (GPO) for government healthcare facilities, operated by the Minnesota Office of State Procurement. The procurement seeks to establish a contract for pharmaceutical and over-the-counter product suppliers, with a comprehensive solicitation available for download on the Minnesota OSP website. Interested vendors must download four associated documents by providing an email address, which will be used to notify potential suppliers of any official addendums. The RFP requires detailed product submissions, including potential additional proposed products through Exhibit C. Proposals are due on March 5, 2025, at 2:00 p.m. Central Time, with vendors required to submit through the ePro submission system according to the provided instructions.

While specific set-aside designations are not explicitly detailed in the procurement notice, the RFP appears open to pharmaceutical and medical product suppliers capable of meeting government healthcare facility needs. The solicitation includes a sample agreement (Exhibit A) which likely outlines specific vendor qualifications and performance expectations. Vendors will need to demonstrate capability in supplying a wide range of generic and multisource pharmaceuticals and over-the-counter products to government healthcare facilities. The procurement is structured as a cooperative purchasing agreement, potentially allowing multiple vendors to be awarded contracts. Interested parties with questions are directed to contact MMCAP_Infuse.RFP@state.mn.us for additional information. While specific contract value or budget range is not specified in the provided documentation, the national scope of MMCAP Infuse suggests a potentially significant procurement opportunity for qualified pharmaceutical suppliers.

Generated 2/27/25, 9:30 AM